From genetic footprinting to antimicrobial drug targets: Examples in cofactor biosynthetic pathways

Journal of Bacteriology

Volumn 184, Issue 16, 2002, Pages 4555-4572

  Gerdes, Svetlana Y ^a   Scholle, Michael D ^a   D'Souza, Mark ^a   Bernal, Axel ^a   Baev, Mark V ^a   Farrell, Michael ^a   Kurnasov, Oleg V ^a   Daugherty, Matthew D ^a   Mseeh, Faika ^a   Polanuyer, Boris M ^a   Campbell, John W ^a   Anantha, Shubha ^a   Shatalin, Konstantin Y ^a   Chowdhury, Shamim A K ^a   Fonstein, Michael Y ^a   Osterman, Andrei L ^a  

^a Integrated Genomics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; COENZYME A; FLAVINE ADENINE NUCLEOTIDE; GENE PRODUCT; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PROTEIN COAD; PROTEIN NADD; PROTEIN RIBF; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BIOSYNTHESIS; CELL FUNCTION; CONTROLLED STUDY; DNA FOOTPRINTING; DRUG TARGETING; ENZYME METABOLISM; ESCHERICHIA COLI; GENETIC ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VALIDATION PROCESS;

ANTI-BACTERIAL AGENTS; COENZYME A; DNA FOOTPRINTING; DNA TRANSPOSABLE ELEMENTS; DRUG DESIGN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FLAVIN MONONUCLEOTIDE; FLAVIN-ADENINE DINUCLEOTIDE; GENOME, BACTERIAL; MUTAGENESIS, INSERTIONAL; NADP; NICOTINAMIDE-NUCLEOTIDE ADENYLYLTRANSFERASE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SUBSTRATE SPECIFICITY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

EID: 0036334571     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.184.16.4555-4572.2002     Document Type: Article

References (103)

1. Systematic identification of essential genes by in vitro mariner mutagenesis
2. A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae
3. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
4. A genome-based approach for the identification of essential bacterial genes
5. Biosynthesis of riboflavin
6. Biosynthesis of riboflavin
7. Selection analyses of insertional mutants using subgenic-resolution arrays
8. Riboflavin auxotrophs of Escherichia coli
9. 3 Linkage groups of the genes of riboflavin biosynthesis in Escherichia coli
10. Transposition of the Lac region of Escherichia coli. I. Inversion of the Lac operon and transduction of Lac by φ80
11. A new Escherichia coli cell-division gene, ftsk
12. The biosynthesis of nicotinamide adenine dinucleotides in bacteria
13. The biosynthesis of coenzyme A in bacteria
14. Genomes OnLine Database (GOLD): A monitor of genome projects world-wide
15. The complete genome sequence of Escherichia coli K-12
16. Study of the operon of riboflavin biosynthesis in Bacillus subtilis. IV. Regulation of the synthesis of riboflavin synthetase. Investigation of riboflavin transport through the cell membrane
17. Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus
18. Cloning and characterization of a eukaryotic pantothenate kinase gene (panK) from Aspergillus nidulans
19. Analysis of gene control signals by DNA fusion and cloning in Escherichia coli
20. Systematic identification of selective essential genes in Helicobacter pylori by genome prioritization and allelic replacement mutagenesis
21. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
22. Utilization and metabolism of NAD by Haemophilus parainfluenzae
23. The deamido-diphosphopyridine nucleotide and diphosphopyridine nucleotide pyrophosphorylases of Escherichia coli and yeast
24. Complete reconstitution of the human coenzyme A biosynthetic pathway via comparative genomics
25. Archaeal shikimate kinase, a new member of the GHMP-kinase family
26. Profile hidden Markov models
27. Human NMN adenylyltransferase: Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties
28. Whole genome random sequencing and assembly of Haemophilus influenzae Rd
29. Holo-(acyl carrier protein) synthase and phosphopantetheinyl transfer in Escherichia coli
30. The minimal gene complement of Mycoplasma genitalium
31. Novel computational methods in anti-microbial target identification
32. Identification of novel essential Escherichia coli genes conserved among pathogenic bacteria
33. Searching for drug targets in microbial genomes
34. Regeneration of insertionally inactivated streptococcal DNA fragments after excision of transposon Tn916 in Escherichia coli: Strategy for targeting and cloning of genes from gram-positive bacteria
35. Purification and characterization of phosphopantetheine adenylyltransferase from Escherichia coli
36. Insertional transposon mutagenesis by electroporation of released Tn5 transposition complexes
37. Tn5/IS50 target recognition
38. Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants
39. Recent advances in large-scale transposon mutagenesis
40. Are we approaching the end of the antibiotic era?
41. Genetic footprinting in bacteria
42. How antibiotics cause antibiotic resistance
43. Transposome insertional mutagenesis and direct sequencing of microbial genomes
44. An indispensable gene for NAD biosynthesis in Salmonella typhimurium
45. Global transposon mutagenesis and a minimal mycoplasma genome
46. The crystal structure of a novel bacterial adenylyltransferase reveals half of sites reactivity
47. Cloning, sequence, and expression of the pantothenate permease (panF) gene of Escherichia coli
48. Identification of nonessential Helicobacter pylori genes using random mutagenesis and loop amplification
49. The Escherichia coli K-12 wild types W3110 and MG1655 have rph frameshift mutation that leads to pyrimidine starvation due to low pyre expression levels
50. Transposon-based approaches to identify essential bacterial genes
51. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage
52. Inactivation of the ypaA gene in Bacillus subtilis; analysis of the resulting phenotypic expression
53. Structural and functional characterization of human NAD kinase
54. Methods for generating precise deletions and insertions in the genome of wild-type Escherichia coli: Application to open reading frame characterization
55. Integrated bacterial genomics for the discovery of novel antimicrobials
56. Enzymology of NAD+ synthesis
57. Purification of human nicotinamide-mononucleotide adenylyltransferase
58. Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence
59. Identification of the Escherichia coli nicotinic acid mononucleotide adenylyltransferase gene
60. EZ:TN transposon insertions into target DNA in vitro are highly random
61. Identification of yacE (coaE) as the structural gene for dephosphocoenzyme A kinase in Escherichia coli K-12
62. Biosynthesis and salvage pathways of pyridine nucleotides
63. Genomics and antimicrobial drug discovery
64. Culture medium for enterobacteria
65. Identification, characterization, and crystal structure of Bacillus subtilis nicotinic acid mononucleotide adenylyltransferase
66. WIT: Integrated system for high-throughput genome sequence analysis and metabolic reconstruction
67. Biosynthesis and recycling of NAD
68. The Escherichia coli NadR regulator is endowed with nicotinamide mononucleotide adenylyltransferase activity
69. Genome scanning in Haemophilus influenzae for identification of essential genes
70. NADP and NAD utilization in Haemophilus influenzae
71. Harnessing the power of the genome in the search for new antibiotics
72. Molecular characterization of FMN1, the structural gene for the monofunctional flavokinase of Saccharomyces cerevisiae
73. Novel approaches to the discovery of antimicrobial agents
74. Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis
75. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus
76. A reconstruction of the metabolism of Methanococcus jannaschii from sequence data
77. Crystal structure of quinolinic acid phosphoribosyltransferase from Mycobacterium tuberculosis: A potential TB drug target
78. Genetic footprinting: A genomic strategy for determining a gene's function given its sequence
79. Functional analysis of the genes of yeast chromosome V by genetic footprinting
80. Cloning, sequencing, and expression of the pantothenate kinase (coaA) gene of Escherichia coli
81. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis
82. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
83. Identification, mapping, and cloning of the gene encoding cyanase in Escherichia coli K-12
84. Clustal-W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
85. Characterization of nadR locus in Escherichia coli
86. Isolation and characterization of Escherichia coli pantothenate permease (panF) mutants
87. Isolation and characterization of temperature-sensitive pantothenate kinase (coaA) mutants of Escherichia coli
88. Phoneme recognition using time-delay neural networks
89. Human placental Na+dependent multivitamin transporter. Cloning, functional expression, gene structure, and chromosomal location
90. FtsK is an essential cell division protein that is localized to the septum and induced as part of the SOS response
91. Genetic footprinting with marinerbased transposition in Pseudomonas aeruginosa
92. Cloning and characterization of FAD1, the structural gene for flavin adenine dinucleotide synthetase of Saccharomyces cerevisiae
93. Crystal structures of E. coli nicotinate mononucleotide adenylyltransferase and its complex with deamido-NAD
94. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide
95. Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin